TY - JOUR
T1 - Involvement of activating transcription factors JNK, NF-κB, and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex
AU - Chen, Sung Ho
AU - Lin, Jen Kun
AU - Liang, Yu Chih
AU - Pan, Min Hsiung
AU - Liu, Shing Hwa
AU - Lin-Shiau, Shoei Yn
PY - 2008/10/10
Y1 - 2008/10/10
N2 - Pyrrolidine dithiocarbamate (PDTC) is a metal chelator. Biologically, slight toxic affects EC50, 100 ± 5.9 μM are observed when added to cultured HL-60 cells. CuCl2 at a physiological concentration (1 μM), but not FeCl2, Pb potentiated the cytotoxic effect of PDTC by 700 fold (EC50, 0.14 ± 0.02 μM). Furthermore, results indicated that the PDTC/Cu complex induced an apoptotic process, evidenced by apoptotic bodies, DNA ladder and hypodiploidy cells. Additional studies showed that PDTC/Cu complex significantly decreased mitochondrial membrane potential, increased cytochrome c release, and reactive oxygen species production, and depleted reduced non-protein thiols in a time-dependent manner. Following oxidative stress, the PDTC/Cu complex sequentially activated JNK, NF-κB and AP-1 signaling pathways while IκB kinase activity was enhanced. The apoptotic process was eventually induced by caspase 3 activation and PARP degradation. The non-permeable copper-specific chelator-bathocuproine disulfonate (BCPS) and vitamin C were able to inhibit apoptosis and the elevation of intracellular Cu. Based on these findings; we conclude that PDTC/Cu complex-induced apoptosis is mediated by activation of JNK, NF-κB, AP-1 and caspase 3. Due to its high potency, PDTC may be useful as a therapeutic anti-cancer drug.
AB - Pyrrolidine dithiocarbamate (PDTC) is a metal chelator. Biologically, slight toxic affects EC50, 100 ± 5.9 μM are observed when added to cultured HL-60 cells. CuCl2 at a physiological concentration (1 μM), but not FeCl2, Pb potentiated the cytotoxic effect of PDTC by 700 fold (EC50, 0.14 ± 0.02 μM). Furthermore, results indicated that the PDTC/Cu complex induced an apoptotic process, evidenced by apoptotic bodies, DNA ladder and hypodiploidy cells. Additional studies showed that PDTC/Cu complex significantly decreased mitochondrial membrane potential, increased cytochrome c release, and reactive oxygen species production, and depleted reduced non-protein thiols in a time-dependent manner. Following oxidative stress, the PDTC/Cu complex sequentially activated JNK, NF-κB and AP-1 signaling pathways while IκB kinase activity was enhanced. The apoptotic process was eventually induced by caspase 3 activation and PARP degradation. The non-permeable copper-specific chelator-bathocuproine disulfonate (BCPS) and vitamin C were able to inhibit apoptosis and the elevation of intracellular Cu. Based on these findings; we conclude that PDTC/Cu complex-induced apoptosis is mediated by activation of JNK, NF-κB, AP-1 and caspase 3. Due to its high potency, PDTC may be useful as a therapeutic anti-cancer drug.
KW - AP-1
KW - Apoptosis
KW - BCPS
KW - Caspase
KW - Copper
KW - JNK
KW - NF-κB
KW - Oxidative stress
KW - PDTC
UR - http://www.scopus.com/inward/record.url?scp=50549096389&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=50549096389&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2008.07.024
DO - 10.1016/j.ejphar.2008.07.024
M3 - Article
C2 - 18671963
AN - SCOPUS:50549096389
SN - 0014-2999
VL - 594
SP - 9
EP - 17
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1-3
ER -